Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress

Circulation

Volumn 106, Issue 16, 2002, Pages 2067-2072

  Esposito, Katherine ^a   Nappo, Francesco ^a   Marfella, Raffaele ^a   Giugliano, Giovanni ^a   Giugliano, Francesco ^a   Ciotola, Myriam ^a   Quagliaro, Lisa ^a   Ceriello, Antonio ^a   Giugliano, Dario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Glutathione; Hyperglycemia; Interleukins; Tumor necrosis factor

Indexed keywords

CYTOKINE; GLUCOSE; GLUTATHIONE; INSULIN; INTERLEUKIN 18; INTERLEUKIN 6; OCTREOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLUTATHIONE; HUMANS; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-6; KINETICS; MALE; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037109184     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000034509.14906.AE     Document Type: Article

References (34)

1. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993;42:8-11.
2. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937-942.
3. Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome. Diabetologia. 1997;40:1286-1292.
4. Pradhan AD, Manson JAE, Rifai N, et al. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
5. Pickup JC, Chusney GD, Thomas SM. et al. Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67:291-300.
6. Amalich F, Hernanz A, Lopez-Maderuelo D, et al. Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res. 2000;32:407-412.
7. Kado S, Nagase T, Nagata N. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol. 1999;36:67-72.
8. Shikano M, Sobajima H, Yoshikawa H, et al. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron. 2000;85:81-85.
9. Mallat Z, Corbaz A, Scoazec A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001;104:1598-1603.
10. Capes SE, Hunt D, Malberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic overview. Lancet. 2000;355:773-778.
11. Giugliano D, Ceriello A. The toxic trio: acute, chronic and post-prandial hyperglycemia. Nutr Metab Cardiovasc Dis. 2001;11:80-83.
12. Ceriello A. The emerging role of post-prandial hyperglycemic spikes in the pathogenesis of diabetic complications. Diabet Med. 1998;15:188-193.
13. Guha M, Bai W, Nadler JL, et al. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem. 2000;275:17728-17739.
14. Ceriello A, Giugliano D, Quatraro A, et al. Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic coinplications? Diabetes Care. 1991;14:68-72.
15. Paolisso G, Giugliano D, Scheen A, et al. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. Acta Endocrinol. 1987;115:161-169.
16. Morohoshi M, Fujisawa K, Uchimura I, et al. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes. 1996;45:954-959.
17. Pampfer S, Vanderheyden I, Hertogh R. Increased synthesis of tumor necrosis factor-alpha in uterine explants from pregnant diabetic rats and in primary cultures of uterine cells in high glucose. Diabetes. 1997;46:1214-1224.
18. Coughlan MT, Oliva K, Georgiu HM, et al. Glucose-induced release of tumor necrosis factor-alpha from human placental tissues in gestational diabetes mellitus. Diabet Med. 2001;18:921-927.
19. Morohoshi M, Fujisawa K, Uchimura I, et al. The effect of glucose and advanced end products on IL-6 production by human monocytes. Ann N Y Acad Sci. 1995;748:562-570.
20. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11 212-217.
21. Tsigos C, Papanicolau DA, Kyrou I, et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab. 1997;82:4167-4170.
22. Fernandez-Real JM, Broch M, Vendrell J. et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes. 2000;49:517-520.
23. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196-4200.
24. Asakawa H, Miyagawa J, Hanafusa T, et al. High glucose and hyperosmolarity increase secretion of interleukin-1 beta in cultured human aortic endothelial cells. J Diabetes Complications. 1997;11:176-179.
25. Okamura H, Tsutsui H, Kashiwamura S, et al. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol. 1998;70:281-312.
26. Gerdes N, Sukhova GK, Libby P, et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 2002;195:245-257.
27. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia. 2001;44:2107-2114.
28. Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol. 2001;281:E924-E930.
29. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
30. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
31. Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149-2153.
32. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-267.
33. Sschmidt AM, Yan SD, Wautier JL, et al. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999;84:489-497.
34. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance via salicylates or targeted disruption of IKKbeta. Science. 2001;293:1673-1677.